Companies / Amgen
Amgen
Company- Registered trials
- 1579
- Ongoing
- 192/ 12%
- Completed
- 1088
- Related drugs
- 11
- Related conditions
- 12
Clinical trial landscape
1579 registered studies reference this company or one of its brands. The split below shows how many are ongoing versus completed per phase.
| Phase | Total | Ongoing | Completed | Split |
|---|---|---|---|---|
| Phase 2 | 464 | 53 | 311 | |
| Phase 3 | 359 | 57 | 267 | |
| Phase 1 | 311 | 31 | 223 | |
| Unknown | 164 | 20 | 106 | |
| Phase 4 | 122 | 8 | 93 | |
| Phase 1/2 | 88 | 13 | 47 | |
| Not applicable | 45 | 6 | 27 | |
| Phase 2/3 | 14 | 2 | 8 | |
| Early Phase 1 | 12 | 2 | 6 | |
| All phases | 1579 | 192 | 1088 |
Ongoing Completed Balance withdrawn, terminated, or status unreported.
Study records: ClinicalTrials.gov →
Recent developments
Headlines link to the original publisher. Sources limited to a reviewed list of journals, regulators, and medical press.